SCHEMBL20510285

SCHEMBL20510285

Cc1oc(=O)oc1COC(=O)SCC(N)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 1/20 0.38
▸ IDO1 P14902 2/20 0.36
▸ CHRM1 P11229 1/20 0.35
▸ TBXA2R P21731 1/20 0.35
▸ ADRA1A P35348 1/20 0.35
▸ GRIA1 P42261 3/20 0.33
▸ GRIA3 P42263 3/20 0.33
▸ MAPT P10636 2/20 0.33
▸ GRIK1 P39086 2/20 0.33
▸ GRIA2 P42262 2/20 0.33
▸ GRIA4 P48058 2/20 0.33
▸ GRIK5 Q16478 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18653856 1.00 FOLH1 (0.38) FOLH1IDO1CHRM1TBXA2RADRA1A
SCHEMBL18653858 0.88 CHRM1 (0.33) FOLH1CHRM1TBXA2RADRA1AALDH1A1
SCHEMBL18631761 0.80 PSMB11 (0.35) FOLH1CHRM1TBXA2RADRA1AMAPT
SCHEMBL18650384 0.80 TYR (0.37) FOLH1CHRM1TBXA2RADRA1A
SCHEMBL20510688 0.80 PSMB11 (0.35) FOLH1CHRM1TBXA2RADRA1AMAPT
SCHEMBL18650397 0.80 PSMB11 (0.35) FOLH1CHRM1TBXA2RADRA1AMAPT
SCHEMBL18653855 0.79 IDO1 (0.41) IDO1KIF11KLKB1
SCHEMBL22939353 0.79 FOLH1 (0.33) FOLH1CHRM1TBXA2RADRA1A
SCHEMBL18660439 0.78 FOLH1 (0.33) FOLH1IDO1CHRM1TBXA2RADRA1A
SCHEMBL17509691 0.77 FOLH1 (0.41) FOLH1CHRM1TBXA2RADRA1AGRIA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018174839-A1 CYSTEINE, N-ACETYLCYSTEINE AND PENICILLAMINE PRODRUGS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE NGUYEN MARK QUANG (US) 2018-09-27 — — WO disclosed
Send feedback